Genmab — December 2014
-
hm.. ja de matcher fint, men jeg er ikke vild med tanken. Jeg tror, at det langsigtede potentiale i Genmab er væsentlig større end et eventuelt bud vil lyde på. Det er selvfølgelig også det, at Gilead eller andre der kunne overveje et tilbud tænker.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
339.9